Vanda Pharmaceuticals FY2026 Revenue expected to be more than $240.000M vs $248.797M Est

Benzinga · 2d ago
Vanda Pharmaceuticals (NASDAQ:VNDA) FY2026 Revenue expected to be more than $240.000M vs $248.797M Est